Status:
COMPLETED
Analysis of CMTM6 Expression in Patients With Acute Myeloid Leukemia
Lead Sponsor:
University of Freiburg
Conditions:
Acute Myeloid Leukemia, Adult
Eligibility:
All Genders
18-99 years
Brief Summary
In this study, we aim to investigate the expression of CKLF like MARVEL transmembrane domain containing 6 (CMTM6) in leukemia cells of patients with acute myeloid leukemia (AML). We will use periphera...
Eligibility Criteria
Inclusion
- age ≥ 18 years
- primary diagnosis of acute myeloid leukemia
- diagnosis results available
- written informed consent
- ability to understand the nature of the study and the study related procedures and to comply with them
Exclusion
- age \< 18 years
- lack of informed consent
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05988047
Start Date
May 1 2020
End Date
May 1 2024
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Center- University of Freiburg
Freiburg im Breisgau, CA, Germany, 79106